Rochester, NY 8/24/2009 8:54:23 PM
Pfizer Inc. PFE , Market Updates on Financial Stocks - Pfizer Inc., Irving Kahn, Citigroup Inc., Bristolmyers Squibb Company
Pfizer Inc. PFE
Pfizer Inc is a research-based global pharmaceutical company that discovers and develops innovative value-added products that improve the quality of life of people around the world and help them enjoy longer healthier and more productive lives. Pfizer has three business segments: health care animal health and consumer health care. Its products are available in numerous countries.
Pfizer Inc has a market cap of $112.29 billion; its shares were traded at around $16.64 with a P/E ratio of 7.2 and P/S ratio of 2.4. The dividend yield of Pfizer Inc stocks is 3.8%. Pfizer Inc had an annual average earning growth of 11% over the past 10 years.
At the age of above 100, Irving Kahn is the only living value investor who experienced the great depression as an adult. Apparently that helped him, as he added greatly into his positions as the market lows. Irving invests mostly in healthcare industry and financials. This is his Q2 portfolio update. Irving Kahn owns 55 stocks with a total value of $372 million. These are the details of the buys and sells.
About Stock Einstein
StockEinstein uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
This service is free and available only to subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
Disclaimer: Full disclaimer at http://StockEinstein.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinstein, nor any of its affiliates are registered investment advisors or broker dealers.
